410 related articles for article (PubMed ID: 10078377)
1. [The current status of research on a cholera vaccine].
Fournier JM
Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):412-5. PubMed ID: 10078377
[TBL] [Abstract][Full Text] [Related]
2. A review of the current status of enteric vaccines.
Levine MM; Noriega F
P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
[TBL] [Abstract][Full Text] [Related]
3. [Cholera update and vaccination problems].
Fournier JM; Villeneuve S
Med Trop (Mars); 1998; 58(2 Suppl):32-5. PubMed ID: 9812307
[TBL] [Abstract][Full Text] [Related]
4. Current status of cholera and rise of novel mucosal vaccine.
Yamamoto T
Jpn J Infect Dis; 2000 Oct; 53(5):181-8. PubMed ID: 11135702
[TBL] [Abstract][Full Text] [Related]
5. Development of Peru-15 (CholeraGarde), a live-attenuated oral cholera vaccine: 1991-2009.
Chowdhury MI; Sheikh A; Qadri F
Expert Rev Vaccines; 2009 Dec; 8(12):1643-52. PubMed ID: 19943759
[TBL] [Abstract][Full Text] [Related]
6. Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR.
Viret JF; Dietrich G; Favre D
Vaccine; 2004 Jun; 22(19):2457-69. PubMed ID: 15193410
[TBL] [Abstract][Full Text] [Related]
7. Oral vaccines for cholera control.
Chaturvedi S; Chaturvedi S
Natl Med J India; 1997; 10(1):17-8. PubMed ID: 9069701
[TBL] [Abstract][Full Text] [Related]
8. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
[TBL] [Abstract][Full Text] [Related]
9. Live attenuated oral cholera vaccines.
Ryan ET; Calderwood SB; Qadri F
Expert Rev Vaccines; 2006 Aug; 5(4):483-94. PubMed ID: 16989629
[TBL] [Abstract][Full Text] [Related]
10. [Vaccines inf the prevention of fecal hazards].
Saliou P
Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):445-9. PubMed ID: 10078383
[TBL] [Abstract][Full Text] [Related]
11. The current status of cholera vaccine development and experience with cholera vaccine trials in volunteers.
Levine MM; Kaper JB; Herrington D; Losonsky G; Tacket C; Tall B
Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):401-15. PubMed ID: 3217822
[TBL] [Abstract][Full Text] [Related]
12. Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam.
Trach DD; Cam PD; Ke NT; Rao MR; Dinh D; Hang PV; Hung NV; Canh DG; Thiem VD; Naficy A; Ivanoff B; Svennerholm AM; Holmgren J; Clemens JD
Bull World Health Organ; 2002; 80(1):2-8. PubMed ID: 11884967
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a detection system for wild-type Vibrio cholerae in genetically modified cholera vaccine.
Studer E; Candrian U
Biologicals; 2000 Sep; 28(3):149-54. PubMed ID: 10964441
[TBL] [Abstract][Full Text] [Related]
14. Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.
Roland KL; Cloninger C; Kochi SK; Thomas LJ; Tinge SA; Rouskey C; Killeen KP
Vaccine; 2007 Dec; 25(51):8574-84. PubMed ID: 18045752
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and protective capacity of inactivated "vibrio cholerae" whole cell vaccines.
Cryz SJ; Fürer E; Germanier R
Dev Biol Stand; 1983; 53():67-72. PubMed ID: 6873478
[TBL] [Abstract][Full Text] [Related]
16. Cholera vaccines.
Ryan ET; Calderwood SB
Clin Infect Dis; 2000 Aug; 31(2):561-5. PubMed ID: 10987721
[TBL] [Abstract][Full Text] [Related]
17. Experimental immunisation and protection of guinea pigs with Vibrio cholerae toxoid and mucinases, neuraminidase and proteinase.
Stewart-Tull DE; Lucas C; Bleakley CR
Vaccine; 2004 Jun; 22(17-18):2137-45. PubMed ID: 15149770
[TBL] [Abstract][Full Text] [Related]
18. [Tolerance and immunogenicity of an oral dose of CVD 103-HgR, a live attenuated Vibrio cholerae 01 strain: a double-blind study of Chilean adults].
Lagos R; Avendaño A; Horwitz I; Prado V; Ferreccio C; Sotomayor V; Losonsky G; Wasserman SS; Cryz S; Kaper JB
Rev Med Chil; 1993 Aug; 121(8):857-63. PubMed ID: 8296092
[TBL] [Abstract][Full Text] [Related]
19. Cholera vaccine: developmental strategies and problems.
Bhadra RK; Dasgupta U; Das J
Indian J Biochem Biophys; 1994 Dec; 31(6):441-8. PubMed ID: 7875711
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a live oral cholera vaccine in human volunteers.
Woodward WE; Gilman RH; Hornick RB; Libonati JP; Cash RA
Dev Biol Stand; 1976; 33():108-12. PubMed ID: 782960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
